Cargando…
Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer
BACKGROUND: The development of paclitaxel-resistance led to the tumor relapse and treatment failure of non-small cell lung cancer. Shikonin has been demonstrated to show anti-cancer activity in many cancer types. The present study aimed to investigate the anti-cancer activity of shikonin in paclitax...
Autores principales: | Zang, Farong, Rao, Yuanquan, Zhu, Xinhai, Wu, Zhibing, Jiang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140387/ https://www.ncbi.nlm.nih.gov/pubmed/32268876 http://dx.doi.org/10.1186/s10020-020-00152-8 |
Ejemplares similares
-
Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway
por: Li, Baiying, et al.
Publicado: (2018) -
Small cell lung cancer treated by radiofrequency ablation: A case report
por: Song, Guo-qiang, et al.
Publicado: (2017) -
Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway
por: Du, Wenzhen, et al.
Publicado: (2019) -
Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
por: Zheng, Hongming, et al.
Publicado: (2018) -
Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling
por: Xu, Ziyan, et al.
Publicado: (2022)